Učitavanje...

A tale of two pities: Autologous melanoma vaccines on the brink

This paper reviews and compares two autologous vaccine technologies for human melanoma that failed to obtain marketing approval after 10–15 y of clinical development—the HSP vaccine invented by Srivastava and developed by the company, Antigenics, and the hapten-modified cellular vaccine invented by...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Berd, David
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2012
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551891/
https://ncbi.nlm.nih.gov/pubmed/22854662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.20923
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!